Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2010 1
2012 1
2014 2
2015 3
2017 1
2018 1
2019 5
2020 3
2021 6
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
De novo design of potent and selective mimics of IL-2 and IL-15.
Silva DA, Yu S, Ulge UY, Spangler JB, Jude KM, Labão-Almeida C, Ali LR, Quijano-Rubio A, Ruterbusch M, Leung I, Biary T, Crowley SJ, Marcos E, Walkey CD, Weitzner BD, Pardo-Avila F, Castellanos J, Carter L, Stewart L, Riddell SR, Pepper M, Bernardes GJL, Dougan M, Garcia KC, Baker D. Silva DA, et al. Among authors: spangler jb. Nature. 2019 Jan;565(7738):186-191. doi: 10.1038/s41586-018-0830-7. Epub 2019 Jan 9. Nature. 2019. PMID: 30626941 Free PMC article.
Targeting cancer metastasis with antibody therapeutics.
Yang H, Kuo YH, Smith ZI, Spangler J. Yang H, et al. Among authors: spangler j. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1698. doi: 10.1002/wnan.1698. Epub 2021 Jan 18. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 33463090 Review.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Kumar D, Mishra A, Lisok A, Kureshi R, Shelake S, Plyku D, Sen R, Doucet M, De Silva RA, Mease RC, Forde PM, Jaffee EM, Desai P, Ganguly S, Gabrielson E, Vaidya D, Spangler JB, Nimmagadda S. Kumar D, et al. Among authors: spangler jb. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2107982118. doi: 10.1073/pnas.2107982118. Proc Natl Acad Sci U S A. 2021. PMID: 34508005 Free PMC article.
Full speed AHEAD in antibody discovery.
Sargunas PR, Spangler JB. Sargunas PR, et al. Among authors: spangler jb. Nat Chem Biol. 2021 Oct;17(10):1011-1012. doi: 10.1038/s41589-021-00838-y. Nat Chem Biol. 2021. PMID: 34211163 No abstract available.
Strategies for Glycoengineering Therapeutic Proteins.
Dammen-Brower K, Epler P, Zhu S, Bernstein ZJ, Stabach PR, Braddock DT, Spangler JB, Yarema KJ. Dammen-Brower K, et al. Among authors: spangler jb. Front Chem. 2022 Apr 13;10:863118. doi: 10.3389/fchem.2022.863118. eCollection 2022. Front Chem. 2022. PMID: 35494652 Free PMC article. Review.
Engineered antibody fusion proteins for targeted disease therapy.
Silver AB, Leonard EK, Gould JR, Spangler JB. Silver AB, et al. Among authors: spangler jb. Trends Pharmacol Sci. 2021 Dec;42(12):1064-1081. doi: 10.1016/j.tips.2021.09.009. Epub 2021 Oct 25. Trends Pharmacol Sci. 2021. PMID: 34706833 Free PMC article. Review.
Weaponizing T-cell receptors through molecular engineering.
Leonard EK, Leff MI, Spangler JB. Leonard EK, et al. Among authors: spangler jb. J Biol Chem. 2019 Apr 12;294(15):5805-5806. doi: 10.1074/jbc.H119.008479. J Biol Chem. 2019. PMID: 30979848 Free PMC article.
38 results